Related Experiment Videos
A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy
Insights
Antenatal corticosteroids significantly reduced necrotizing enterocolitis in infants. This antenatal steroid therapy shows promise for accelerated intestinal maturation with no demonstrated adverse effects at the dosage used.
Area of Science:
- Neonatal Medicine
- Obstetrics
- Pharmacology
Background:
- Antenatal corticosteroids are used to promote fetal lung maturation.
- Potential benefits for fetal intestinal development are less understood.
- Assessing safety and efficacy in a large cohort is crucial.
Purpose of the Study:
- To evaluate the effectiveness of antenatal corticosteroids in accelerating lung maturation.
- To monitor for adverse effects in mothers, fetuses, and infants.
- To investigate the impact on infant intestinal outcomes, specifically necrotizing enterocolitis.
Main Methods:
- A large, multicentered, collaborative, randomized, and blinded trial.
- Involved 696 mothers and 745 infants.
- Collected data on over 100 items related to diagnoses, complications, and outcomes.
Main Results:
- A statistically significant decrease in the incidence of necrotizing enterocolitis was observed in infants exposed to antenatal corticosteroids (P = .002).
- No short-term or long-term adverse effects were demonstrated in the parturient, fetus, or infant at the utilized dosage.
- Suggests potential for accelerated intestinal maturation.
Conclusions:
- Antenatal maternal steroid therapy may accelerate intestinal maturation.
- The treatment demonstrated a significant reduction in necrotizing enterocolitis.
- The regimen appears safe and effective at the studied dosage, with no adverse effects identified.
Abstract:
In a large multicentered, collaborative randomized and blinded trial utilizing antenatal corticosteroids, the goals included determining the effectiveness of these agents in accelerating lung maturation, as well as monitoring any short-term or long-term adverse effects of this treatment on the parturient, fetus, and/or infant. More than 100 specific items, pertaining to diagnoses, complications, and outcomes were recorded for the 696 mothers enrolled in the study and their 745 infants. A significantly decreased incidence of necrotizing enterocolitis (P = .002) was found in the infants treated with steroids. The possibility of accelerated intestinal maturation induced by antenatal maternal steroid therapy exists. This treatment regimen is particularly attractive as adverse aspects of steroid therapy at the dosage utilized have not been demonstrated.